Secretary. (D) Transparency to pharmacy For plan years beginning on or after January 1, 2025, the Secretary shall establish a uniform process under which a PDP sponsor offering a prescription drug plan and an MA organization offering an MA–PD plan shall promptly disclose, upon receiving a claim for a covered part D drug from a pharmacy, to such pharmacy all pricing components related to such claim, including the Network Reimbursement ID used to price the claim, any service fees and other fees, pharmacy price concessions, discounts, incentives or anything else of value to or from the pharmacy. (E) Specialty pharmacy For purposes of this subparagraph and section 1860D–4(b)(1)(C), not later than December 31, 2024, the Secretary shall define the term specialty pharmacy in consultation with all relevant stakeholders. (F) Definitions For purposes of this subparagraph: (i) Affiliated The term affiliated means, with respect to a pharmacy, a PDP sponsor offering a prescription drug plan, or an MA organization offering an MA–PD plan, that the pharmacy, PDP sponsor, or MA organization— (I) is directly or indirectly through one or more intermediaries wholly or partially owned by, controlled by, or is under common ownership of such pharmacy, PDP sponsor, or MA organization